Acurx Pharmaceuticals
ACXP
ACXP
32 hedge funds and large institutions have $1.33M invested in Acurx Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $1.36M → $1.33M (-$33.4K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
32
Holding in Top 10
–
Calls
$33K
Puts
$29K
Top Buyers
| 1 | +$434K | |
| 2 | +$28.2K | |
| 3 | +$28.1K | |
| 4 |
Renaissance Technologies
New York
|
+$24.6K |
| 5 |
OBGC
O'Brien Greene & Co
Media,
Pennsylvania
|
+$24.2K |
Top Sellers
| 1 | -$790K | |
| 2 | -$155K | |
| 3 | -$28.1K | |
| 4 |
BlackRock
New York
|
-$13.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$10.1K |